2 Minute Medicine Rewind April 17, 2023

Low-Value Prostate-Specific Antigen Screening in Older Males 1. This retrospective cohort study demonstrated that males over the age of 70 are overscreened for prostate cancer, despite current guidelines advising against screening in this population. Evidence Rating Level: 2 (Good) PSA screening may reduce mortality associated with prostate cancer, though it is also associated with overtreatment,